TRISENOX 2 mg/ml, concentrate for solution for infusion 10 bottles of 6 ml
Active ingredients: TRIOXYDE D'ARSENIC
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only, hospital use
Concentrate for solution for infusion10 bottles of 6 mlintraveineuse
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- TRISENOX 2 mg/mL, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 6 ml
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Apr 2020
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61128000CIP75506518CIP133400955065180Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRIOXYDE D'ARSENICsolution | 2 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.